N-substituted cycloalkyl and polycycloalkyl alpha-substituted Tr

Details N-substituted cycloalkyl and polycycloalkyl alpha-substituted Tr N-substituted cycloalkyl and polycycloalkyl alpha-substituted Tr

1993-05-27

1996-11-12

Nucker, Christine M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

530331, A61K 3805, C07K 500

Patent

active

055740138

ABSTRACT:
Novel peptoids of .alpha.-substituted Trp derivatives useful as agents in the treatment of obesity, hypersecretion of gastric acid in the gut, gastrin-dependent tumors, or as antipsychotics are disclosed. Further the compounds are antianxiety agents and antiulcer agents. They are agents useful for preventing the response to withdrawal from chronic treatment or use of nicotine, diazepam, alcohol, cocaine, caffeine, or opioids. The compounds are also useful in the treatment and/or prevention of panic attacks. Also disclosed are pharmaceutical compositions and methods of treatment using the peptoids as well as processes for preparing them and novel intermediates useful in their preparation. An additional feature of the invention is the use of the subject compounds to prepare diagnostic compositions.

REFERENCES:
patent: 4757151 (1988-07-01), Horwell
patent: 4814463 (1989-03-01), Kim
patent: 4902708 (1990-02-01), Kim
patent: 5010076 (1991-04-01), Waldeck et al.
Danho et al., Int. J. Peptide and Protein Res. 39 (1992) 337-347.
Tilley et al., Int. J. Peptide and Protein Res. 39 (1992) 322-336.
Brain Research, 288 (1983) 199-211. G. W. Roberts et al., "Peptides, the Limbic Lobe and Schizophrenia".
Brain Research, 406 (1987) 130-135. B. A. MacVicar et al., "Inhibition of synaptic transmission in the hippoaampus by . . . ".
British Medical Bulletin, (1982) , v. 38, No. 3, pp. 253-258, G. J. Dockray, "The Physiology of Cholecystokinin in Brain and Gut".
Cancer Research, 46, 1612-1616, Apr. 1986, P. Singh et al., "Role of Gastrin and Gastrin Receptors on the Growth of a Transplantable . . . ".
CCK in the Nervous System, Ch. 7, pp. 110-127, M. J. Sheehan et al., "Central Actions of Cholecystokinin: Behavioral and Release Studies".
Gastroenterology, 1988; v. 95, No. 6, pp. 1541-1548, J. Palmer Smith et al., "Effects of Gastrin, Proglumide, and Somatostatin . . . ".
Gastrointestinal Hormones, 1980, Ch. 7, pp. 169-221, Viktor Mutt, "Cholecystokinin: Isolation, Structure, and Functions".
Ibid., Ch. 22, pp. 507-527, Leonard R. Johnson, "Effect of Gastrointestinal Hormones on Growth of Gastrointestinal Tissue".
Ibid., Ch. 23, pp. 529-564, Stanislaw J. Konturek, "Gastrointestinal Hormones and Gastric Secretion".
Ibid., Ch. 30, pp. 729-739, Fl. Stadil. "Gastrinomas".
Life Sciences, v. 27, pp. 355-368, John E. Morley, "The Neuroendocrine Control of Appetite: The Role of the Endogenous Opiates . . . ".
Journal of Neurochemistry, v. 32, pp. 1339-1341, "Immunochemical Evidence of Cholecystokinin Tetrapeptides in Hog Brain".
Neuropharmacology, v. 26, No. 4, pp. 289-300, 1987, R. G. Hill et al., "Antinociceptive Action of Cholecystokinin Octapeptide (CCK 8) . . . ".
Journal of Neuroscience, Mar. 1988, 8(3):988-1000, H. Demeulemeester, et al., "Heterogeneity of GABAergic Cells in Cat Visual Cortex".
Neuroscience, v. 19, No. 1, pp. 181-192, 1986, S. Totterdell et al., "Cholecystokinin-immunoreactive Boutons in Synaptic Contact . . . ".
Peptides, v. 4, pp. 749-753, 1983, L. H. Schneider et al., "CCK-8 Modulation of Mesolimbic Dopamine: Antagonism of Amphetamine- . . . ".
Goodman and Gilman's The Pharmacological Basis of Therapeutics, 7th ed. (1985), Ch. 17, S. C. Harvey, "Hypnotics and Sedatives".
Pharmacology Biochemistry & Behaviour, v. 30, pp. 309-317, 1988, Friedbert Weiss, et al., "Opposite Actions of CCK-8 on . . . ".
Regulatory Peptides, 14 (1986) 277-291, R. R. Schick et al., "Intracerebroyentricular injections of cholecystokinin . . . ".
Science, v. 206, Oct. 26, 1979, pp. 471-473, "Cholecystokinin Octapeptide: Continuous Picomole Injections into the Cerebral . . . ".
Trends in Pharmacological Sciences, v. 11, Jul. 1990, pp. 271-273, "Cholecystokinin and Anxiety".
Copending application USSN 07/576,308 filed Aug. 31, 1990.
Copending application USSN 07/576,628 filed Aug. 31, 1990.
Copending application USSN 07/576,296 filed Aug. 31, 1990.
Copending application USSN 07/576,315 filed Aug. 31, 1990.
Copending application USSN 07/576,297 filed Aug. 31, 1990.
Copending application USSN 07/545,222 filed Jun. 28, 1990.

Affiliated with

Also associated with

Rating

N-substituted cycloalkyl and polycycloalkyl alpha-substituted Tr does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with N-substituted cycloalkyl and polycycloalkyl alpha-substituted Tr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-substituted cycloalkyl and polycycloalkyl alpha-substituted Tr will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-562567